-
Product Insights
NewNet Present Value Model: Madrigal Pharmaceuticals Inc’s Resmetirom
Empower your strategies with our Net Present Value Model: Madrigal Pharmaceuticals Inc's Resmetirom report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Addictive Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Addictive Disorders - Drugs In Development, 2023’, provides an overview of the Addictive Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Addictive Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alcohol Addiction – Drugs In Development, 2023
Global Markets Direct’s, ‘Alcohol Addiction - Drugs In Development, 2023’, provides an overview of the Alcohol Addiction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ondansetron Hydrochloride in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ondansetron Hydrochloride in Alcohol Dependence Drug Details: Ondansetron (AD-04) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride in Alcohol Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ondansetron Hydrochloride in Alcohol Addiction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride in Alcohol AddictionDrug Details:Ondansetron (AD-04) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IO-102 in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IO-102 in Non-Small Cell Lung Cancer Drug Details:IO-102 is under development for the treatment of metastatic...
-
Company Profile
Adial Pharmaceuticals Inc – Company Profile
Adial Pharmaceuticals Inc (Adial Pharma) is a clinical-stage biopharmaceutical company that develops therapeutic agents. The company's pipeline product include AD04, is for the treatment of alcohol use disorder.The company focuses on developing pharmaceutical treatments for addictions and addictive disorders and related diseases and disorders. Adial Pharma offers clinical services. It markets its product under the brand name such as ONWARD. It is also conducting the clinical phase of the ONWARD pivotal phase 3 clinical trial for the potential treatment of...
Add to Basket -
Product Insights
Net Present Value Model: Ondansetron Hydrochloride
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ondansetron Hydrochloride Drug Details Ondansetron (AD-04)...
-
Product Insights
Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
A wound is a breakdown in the protective function of the skin (the loss of continuity of epithelium) with or without loss of underlying connective tissue (i.e. muscle, bone, nerves) following injury to the skin or underlying tissues/ organs caused by surgery, a blow, a cut, chemicals, heat/ cold, friction/ shear force, pressure or as a result of diseases, such as leg ulcers or carcinomas. The Wounds pipeline drugs market research report provides comprehensive information on the therapeutics under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ondansetron hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ondansetron hydrochloride Drug Details Ondansetron hydrochloride is under development for the treatment of nausea...